JP2014525749A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014525749A5 JP2014525749A5 JP2014524381A JP2014524381A JP2014525749A5 JP 2014525749 A5 JP2014525749 A5 JP 2014525749A5 JP 2014524381 A JP2014524381 A JP 2014524381A JP 2014524381 A JP2014524381 A JP 2014524381A JP 2014525749 A5 JP2014525749 A5 JP 2014525749A5
- Authority
- JP
- Japan
- Prior art keywords
- nucleic acid
- acid molecule
- host cell
- microparticle
- colitis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 150000007523 nucleic acids Chemical class 0.000 claims 10
- 102000039446 nucleic acids Human genes 0.000 claims 10
- 108020004707 nucleic acids Proteins 0.000 claims 10
- 239000011859 microparticle Substances 0.000 claims 6
- 239000003814 drug Substances 0.000 claims 4
- 208000022559 Inflammatory bowel disease Diseases 0.000 claims 3
- 239000002773 nucleotide Substances 0.000 claims 3
- 125000003729 nucleotide group Chemical group 0.000 claims 3
- 239000008194 pharmaceutical composition Substances 0.000 claims 3
- 208000009137 Behcet syndrome Diseases 0.000 claims 1
- 206010009895 Colitis ischaemic Diseases 0.000 claims 1
- 206010056979 Colitis microscopic Diseases 0.000 claims 1
- 206010009900 Colitis ulcerative Diseases 0.000 claims 1
- 241000588724 Escherichia coli Species 0.000 claims 1
- 201000006704 Ulcerative Colitis Diseases 0.000 claims 1
- 240000008042 Zea mays Species 0.000 claims 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims 1
- 230000001580 bacterial effect Effects 0.000 claims 1
- 206010009887 colitis Diseases 0.000 claims 1
- 208000008609 collagenous colitis Diseases 0.000 claims 1
- 230000000295 complement effect Effects 0.000 claims 1
- 235000005822 corn Nutrition 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 235000013305 food Nutrition 0.000 claims 1
- 210000001035 gastrointestinal tract Anatomy 0.000 claims 1
- 208000027138 indeterminate colitis Diseases 0.000 claims 1
- 201000008222 ischemic colitis Diseases 0.000 claims 1
- 208000004341 lymphocytic colitis Diseases 0.000 claims 1
- 239000006041 probiotic Substances 0.000 claims 1
- 230000000529 probiotic effect Effects 0.000 claims 1
- 235000018291 probiotics Nutrition 0.000 claims 1
- 230000001737 promoting effect Effects 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP11006650 | 2011-08-12 | ||
| EP11006650.3 | 2011-08-12 | ||
| EP11185604 | 2011-10-18 | ||
| EP11185604.3 | 2011-10-18 | ||
| PCT/EP2012/065568 WO2013023982A1 (en) | 2011-08-12 | 2012-08-09 | Novel compounds for the treatment of inflammatory bowel disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2014525749A JP2014525749A (ja) | 2014-10-02 |
| JP2014525749A5 true JP2014525749A5 (enExample) | 2015-08-20 |
Family
ID=46826440
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014524381A Ceased JP2014525749A (ja) | 2011-08-12 | 2012-08-09 | 炎症性腸疾患の治療のための新規化合物 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20140199402A1 (enExample) |
| EP (1) | EP2742137A1 (enExample) |
| JP (1) | JP2014525749A (enExample) |
| AU (1) | AU2012296977A1 (enExample) |
| CA (1) | CA2840030A1 (enExample) |
| WO (1) | WO2013023982A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014189850A1 (en) * | 2013-05-20 | 2014-11-27 | The United States Of America, As Represented By The Secretary, Department Of Health & Human Services | Detection and treatment of irritable bowel syndrome |
| WO2015061568A1 (en) * | 2013-10-23 | 2015-04-30 | The J. David Gladstone Institutes, A Testamentary Trust Established Under The Will Of J. David Gladstone | Reprogramming cardiomyocytes with one transcription factor |
| KR102733066B1 (ko) * | 2015-06-26 | 2024-11-21 | 주식회사 파마리서치 | 어류의 정액 또는 정소로부터 분리된 dna 단편 혼합물을 포함하는 허혈성 장염의 예방 또는 치료용 조성물 |
| WO2016208880A1 (ko) * | 2015-06-26 | 2016-12-29 | 주식회사 파마리서치프로덕트 | 어류의 정액 또는 정소로부터 분리된 dna 단편 혼합물을 포함하는 허혈성 장염의 예방 또는 치료용 조성물 |
| US12409190B2 (en) | 2019-05-14 | 2025-09-09 | Hadasit Medical Research Services & Development Ltd. | Milk derived extracellular vesicles for use in treating inflammatory bowel disease |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6770291B2 (en) | 1996-08-30 | 2004-08-03 | The United States Of America As Represented By The Department Of Health And Human Services | Liposome complexes for increased systemic delivery |
| EP2314688B1 (en) | 2004-11-12 | 2014-07-16 | Asuragen, Inc. | Methods and compositions involving miRNA and miRNA inhibitor molecules |
| CA2710713C (en) * | 2007-12-27 | 2017-09-19 | Protiva Biotherapeutics, Inc. | Silencing of polo-like kinase expression using interfering rna |
| US20110117111A1 (en) * | 2008-03-26 | 2011-05-19 | Johns Hopkins University | Microrna-based diagnostic testing and therapies for inflammatory bowel disease and related diseases |
| WO2010034479A1 (en) * | 2008-09-23 | 2010-04-01 | Eth Zurich | Protective e. coli strains for reducing the salmonella typhimurium pathogen load in the intestines |
-
2012
- 2012-08-09 US US14/238,443 patent/US20140199402A1/en not_active Abandoned
- 2012-08-09 WO PCT/EP2012/065568 patent/WO2013023982A1/en not_active Ceased
- 2012-08-09 CA CA2840030A patent/CA2840030A1/en not_active Abandoned
- 2012-08-09 JP JP2014524381A patent/JP2014525749A/ja not_active Ceased
- 2012-08-09 AU AU2012296977A patent/AU2012296977A1/en not_active Abandoned
- 2012-08-09 EP EP12756389.8A patent/EP2742137A1/en not_active Withdrawn